
{"id":1237,"date":"2020-06-17T10:21:47","date_gmt":"2020-06-17T07:21:47","guid":{"rendered":"https:\/\/www.ihu.gr\/ucips\/?p=1237"},"modified":"2020-12-05T10:19:34","modified_gmt":"2020-12-05T08:19:34","slug":"webinar-on-biosecurity","status":"publish","type":"post","link":"https:\/\/www.ihu.gr\/ucips\/post-1237","title":{"rendered":"Open Webinar on Biosecurity"},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-bg-size:cover;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-1\"><h2>Webinar on Biosecurity<\/h2>\n<p>By Dr. Patrick Rudelsheim, Dr. Gijsbert van Willigen<\/p>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-first\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-2\"><p><a class=\"fusion-modal-text-link\" href=\"#\" data-toggle=\"modal\" data-target=\".fusion-modal.PatrickRudelsheim\"><img decoding=\"async\" class=\"alignleft size-full wp-image-1244\" src=\"https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/PatrickRudelsheim.jpg\" alt=\"\" width=\"170\" height=\"170\" srcset=\"https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/PatrickRudelsheim-66x66.jpg 66w, https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/PatrickRudelsheim-150x150.jpg 150w, https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/PatrickRudelsheim.jpg 170w\" sizes=\"(max-width: 170px) 100vw, 170px\" \/><\/a><\/p>\n<\/div><div class=\"fusion-text fusion-text-3\"><p><a class=\"fusion-modal-text-link\" href=\"#\" data-toggle=\"modal\" data-target=\".fusion-modal.PatrickRudelsheim\">Dr. Patrick Rudelsheim<\/a><\/p>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_6 1_6 fusion-one-sixth\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-4\"><p><a class=\"fusion-modal-text-link\" href=\"#\" data-toggle=\"modal\" data-target=\".fusion-modal.GijsbertvanWilligen\"><img decoding=\"async\" class=\"alignleft size-full wp-image-1243\" src=\"https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/GijsbertvanWilligen.jpg\" alt=\"\" width=\"170\" height=\"170\" srcset=\"https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/GijsbertvanWilligen-66x66.jpg 66w, https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/GijsbertvanWilligen-150x150.jpg 150w, https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/GijsbertvanWilligen.jpg 170w\" sizes=\"(max-width: 170px) 100vw, 170px\" \/><\/a><\/p>\n<\/div><div class=\"fusion-text fusion-text-5\"><p><a class=\"fusion-modal-text-link\" href=\"#\" data-toggle=\"modal\" data-target=\".fusion-modal.GijsbertvanWilligen\">Dr. Gijsbert van Willigen<\/a><\/p>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last\" style=\"--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% + 4% ) * 0.66666666666667 ) );\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-6\"><p>The international Hellenic University invites you to attend an\u00a0<b>open\u00a0<strong>Webinar on Biosecurity<\/strong><\/b>, held via the Software Zoom (<a href=\"https:\/\/zoom.us\/\" target=\"_blank\" rel=\"noopener noreferrer\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/zoom.us\/&amp;source=gmail&amp;ust=1592470599102000&amp;usg=AFQjCNFS2ZuUuDDOdQG9COqRNlkPBNRJEw\">https:\/\/zoom.us\/<\/a>),\u00a0<strong>on Thursday 2 July, at 18.00-20.00 CET (19.00-21.00 Greek Time). <\/strong>Please register at: <a href=\"https:\/\/e-services.ihu.edu.gr\/registration-form\/1620\/online-form\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/e-services.ihu.edu.gr\/registration-form\/1620\/online-form<\/a>.<\/p>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-bg-size:cover;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-7\"><p><a href=\"https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/Event_FB.jpg\"><img decoding=\"async\" class=\"size-full wp-image-1238 aligncenter\" src=\"https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/Event_FB.jpg\" alt=\"\" width=\"1200\" height=\"675\" srcset=\"https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/Event_FB-200x113.jpg 200w, https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/Event_FB-300x169.jpg 300w, https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/Event_FB-400x225.jpg 400w, https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/Event_FB-600x338.jpg 600w, https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/Event_FB-768x432.jpg 768w, https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/Event_FB-800x450.jpg 800w, https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/Event_FB-1024x576.jpg 1024w, https:\/\/www.ihu.gr\/ucips\/wp-content\/uploads\/sites\/4\/2020\/06\/Event_FB.jpg 1200w\" sizes=\"(max-width: 1200px) 100vw, 1200px\" \/><\/a><\/p>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-5 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-bg-size:cover;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-8\"><h3>Summary<\/h3>\n<p>Some biological materials have the capacity to cause harm. For most people involved in life science this is the justification for implementing laboratory biosafety based on containment principles, technologies, and practices to protect people from biological agents, and prevent accidental release of biological agents. Yet, the capacity to cause harm can also be misused and laboratory biosecurity measures therefore aim to prevent theft and intentional malicious use of biological agents. Special attention is required for so-called dual-use goods, materials that have a civilian and a military application. Dual-use biological agents can be used in bioterrorism.<\/p>\n<p>Besides the wild type agents themselves, biological agents can also be modified in the lab to become more dangerous than the wild-type organism itself. This is called dual-use research of concern (DURC). One type of DURC research is gain-of-function (GOF) research. Besides the risks of dual-use agents and DURC\/GOF also ethical questions can arise from the application of GOF.<\/p>\n<p>Understanding these security threats, both biosafety and biosecurity should be an integral part of program management of organizations handling dangerous pathogens, in order to prevent potential undesired spread, theft, malicious use, and bioterrorism.<\/p>\n<p>The lecture will focus on:<\/p>\n<ul>\n<li>what should be part of a proper laboratory biosecurity program and who are stakeholders in the program<\/li>\n<li>what are dual-use materials<\/li>\n<li>what are dual-use biological agents are and the basis why agents are classified as dual-use. The criteria include besides the pathogenicity also other factor such a how can they be cultured and dispersed.<\/li>\n<li>types of research will be presented as examples of DURC\/GOF and published examples will be discussed.<\/li>\n<li>ethical questions<\/li>\n<\/ul>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-3 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-6 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-bg-size:cover;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy\"><div class=\"fusion-modal modal fade modal-1 PatrickRudelsheim\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"modal-heading-1\" aria-hidden=\"true\" style=\"--awb-border-color:#e7e4e2;--awb-background:#faf9f8;\"><div class=\"modal-dialog modal-lg\" role=\"document\"><div class=\"modal-content fusion-modal-content\"><div class=\"modal-header\"><button class=\"close\" type=\"button\" data-dismiss=\"modal\" aria-hidden=\"true\" aria-label=\"Close\">&times;<\/button><h3 class=\"modal-title\" id=\"modal-heading-1\" data-dismiss=\"modal\" aria-hidden=\"true\">Dr. Patrick Rudelsheim<\/h3><\/div><div class=\"modal-body fusion-clearfix\">\n<p>Trained as a biologist, Patrick R\u00fcdelsheim started his career in a Dutch seed company. He then joined Plant Genetic Systems N.V., Ghent, Belgium. After being in charge of Product Development and Registration, he was appointed Director Regulatory Affairs and Member of the Board.<\/p>\n<p>Following the acquisition of PGS, he became Global Head of Biotechnology Regulatory Affairs for the AgrEvo group and remained in this function during the subsequent creation of Aventis S.A. and the acquisition by Bayer. In this function, he ensured the scientific argumentation for Product Safety and Quality as well as the compliance with all regulatory acquirements related to genetic engineering.<\/p>\n<p>In 2003, he founded and became General Partner of Perseus BVBA, a service company focused on bio-safety and related regulatory requirements. In this capacity he offers his extensive and global experience in every aspect of biosafety and biotechnology regulation to a range of users and developers.<\/p>\n<\/div><div class=\"modal-footer\"><button class=\"fusion-button button-default button-medium button default medium\" type=\"button\" data-dismiss=\"modal\">Close<\/button><\/div><\/div><\/div><\/div><div class=\"fusion-modal modal fade modal-2 GijsbertvanWilligen\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"modal-heading-2\" aria-hidden=\"true\" style=\"--awb-border-color:#e7e4e2;--awb-background:#faf9f8;\"><div class=\"modal-dialog modal-lg\" role=\"document\"><div class=\"modal-content fusion-modal-content\"><div class=\"modal-header\"><button class=\"close\" type=\"button\" data-dismiss=\"modal\" aria-hidden=\"true\" aria-label=\"Close\">&times;<\/button><h3 class=\"modal-title\" id=\"modal-heading-2\" data-dismiss=\"modal\" aria-hidden=\"true\">Dr. Gijsbert van Willigen<\/h3><\/div><div class=\"modal-body fusion-clearfix\">\n<p>Gijsbert van Willigen is the biosrisk management professional of the Leiden University Medical Center in the Netherlands. After his study Biology at the Catholic University of Nijmegen (1987), he did his PhD at the Academic Hospital Utrecht in the field of thrombosis and hemostasis (1992). After several post-doc positions at the University Medical Center Utrecht and a sabbatical at the University of Helsinki (2000) he started as a biosafety Officer at the UMC Utrecht. In 2002 he switched to the Leiden University Medical Center and since then has a position as biosrisk management professional.<\/p>\n<p>As a biosafety officer he has been admitted by the Dutch authorities for several containment levels up to (A)BSL3. His field of expertise include biosafety and biosecurity in laboratories and animal experiments in high containment facilities ((A)BLS3) and the use of genetically modified organism in a clinical setting (gene therapy). He has been involved the construction of several BSL3 facilities in the Netherlands and is now involved in the construction of a new GAPII\/BSL3 facility at the National Institute of Public Health.<\/p>\n<p>Between 2014-2018 he was member of the council of the European Biosafety Association; President of EBSA in 2016-2017. His present position within EBSA is chair of the Conference Program Working Group.<\/p>\n<p>Further details see: <a href=\"http:\/\/nl.linkedin.com\/in\/gvanwilligen\" target=\"_blank\" rel=\"noopener noreferrer\">http:\/\/nl.linkedin.com\/in\/gvanwilligen<\/a><\/p>\n<\/div><div class=\"modal-footer\"><button class=\"fusion-button button-default button-medium button default medium\" type=\"button\" data-dismiss=\"modal\">Close<\/button><\/div><\/div><\/div><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4],"tags":[],"class_list":["post-1237","post","type-post","status-publish","format-standard","hentry","category-events"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ihu.gr\/ucips\/wp-json\/wp\/v2\/posts\/1237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ihu.gr\/ucips\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ihu.gr\/ucips\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ihu.gr\/ucips\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ihu.gr\/ucips\/wp-json\/wp\/v2\/comments?post=1237"}],"version-history":[{"count":0,"href":"https:\/\/www.ihu.gr\/ucips\/wp-json\/wp\/v2\/posts\/1237\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ihu.gr\/ucips\/wp-json\/wp\/v2\/media?parent=1237"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ihu.gr\/ucips\/wp-json\/wp\/v2\/categories?post=1237"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ihu.gr\/ucips\/wp-json\/wp\/v2\/tags?post=1237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}